Nova Patents
AT530180T

Means of ascertaining an individual's risk profile for atherosclerotic disease

Abstract

The invention involves methods for characterising an individual's risk profile of developing a future cardiovascular disorder by obtaining a level of a marker of systemic inflammation, such as C-reactive protein, in the individual. The invention also involves methods for evaluating the likelihood that an individual will benefit from treatment with an agent for reducing the risk of future cardiovascular disorder.

Term

Term ended

Expired 2 April 2018, 8.5 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

46 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
4195097United States of AmericaP
4303997United States of AmericaP
7089498United States of AmericaP

Members46

Family members, oldest first
DocumentOfficeKind
CA2285091A1CanadaA1
WO9843630A1World Intellectual Property Organization (WIPO)A1
AU7100898AAustraliaA
US6040147AUnited States of AmericaA
EP1003501A1European Patent Office (EPO)A1
EP1003501A4European Patent Office (EPO)A4
CA2381926A1CanadaA1
WO0115744A1World Intellectual Property Organization (WIPO)A1
AU7110300AAustraliaA
JP2001525058AJapanA
EP1212101A1European Patent Office (EPO)A1
WO0115744A9World Intellectual Property Organization (WIPO)A9
JP2003508453AJapanA
JP2003128582AJapanA
EP1493439A1European Patent Office (EPO)A1
EP1003501B1European Patent Office (EPO)B1
AT290375TAustriaT
ATE290375T1AustriaT1
EP1520590A1European Patent Office (EPO)A1
DE69829293D1GermanyD1
EP1003501B9European Patent Office (EPO)B9
DK1003501T3DenmarkT3
AU782386B2AustraliaB2
PT1003501EPortugalE
ES2239801T3SpainT3
AU2005225101A1AustraliaA1
DE69829293T2GermanyT2
US7030152B1United States of AmericaB1
US2006104941A1United States of AmericaA1
JP3805381B2JapanB2
AU782386CAustraliaC
EP1767222A1European Patent Office (EPO)A1
EP1767223A1European Patent Office (EPO)A1
JP2008120800AJapanA
EP2305235A1European Patent Office (EPO)A1
EP2305236A1European Patent Office (EPO)A1
US7964614B2United States of AmericaB2
EP1493439B1European Patent Office (EPO)B1
AT530180TThis recordAustriaT
ATE530180T1AustriaT1
PT1493439EPortugalE
DK1493439T3DenmarkT3
ES2374621T3SpainT3
JP2013036996AJapanA
JP2015079003AJapanA
CY1112261T1CyprusT1